SCT200
SCT200 is a fully humanized IgG1 anti-EGFR monoclonal antibody with a Kd of 0.08 nM. SCT200 can kill tumor cells by complement-dependent cytotoxicity (CDC) and antibody-dependent cellular cytotoxicity (ADCC) through the Fc. SCT200 can be used for the study of refractory RAS and BRAF wild-type metastatic colorectal cancer[1].
Product Specifications
UNSPSC
12352203
Target
EGFR
Related Pathways
JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
References & Citations
[1]Yang L, et al. Efficacy, safety and genomic analysis of SCT200, an anti-EGFR monoclonal antibody, in patients with fluorouracil, irinotecan and oxaliplatin refractory RAS and BRAF wild-type metastatic colorectal cancer: a phase II study. EBioMedicine. 2024 Feb;100:104966.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
More Discoveries
Explore Other Products
Browse additional items from our catalog
27745066 1.0 µg DNA
LSM2 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)
Sign In for Pricing
View Details 
MBS2905407-01 48 Well
Human MAEA / E3 ubiquitin-protein transferase MAEA ELISA Kit
Sign In for Pricing
View Details MBS2905407-02 96 Well
Human MAEA / E3 ubiquitin-protein transferase MAEA ELISA Kit
Sign In for Pricing
View Details MBS2905407-03 5x 96 Well
Human MAEA / E3 ubiquitin-protein transferase MAEA ELISA Kit
Sign In for Pricing
View Details